Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board hears warnings on specialty drugs as share of pharmacy spend grows
Summary
Aon consultant Paige told the board specialty drugs now account for nearly 30% of drug spend and could exceed 50% of drug trend in 3–5 years; commissioners pressed for clearer charting, explanation of rebates and site‑of‑care costs and the implications for rate setting.
An Aon consultant summarized national and local pharmacy trends, telling the Health Service Board that the growth in specialty drug spending is shifting how employers and plans must manage pharmacy benefits.
“Specialty drugs usually are used by about 1 to 2 percent of the population, but they now account for almost 30% of drug costs,” the presenter said, and projected that in the next three to five years…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
